Average Wholesale Price for Prescription Drugs: Is There a More Appropriate Pricing Mechanism?
July 12, 2002
Dawn M. Gencarelli
This meeting examined the role of the average wholesale price (AWP) in prescription drug pricing and reimbursement and highlighted some of the problems that have emerged as a result of the way in which AWPs are reported and used. Speakers discussed how the AWP is used within the context of the Medicare and Medicaid programs, as well as in the private market. Discussion focused on existing proposals for reform and the possible implications of such changes.
Anna Cook, PhD, Principal Analyst, U.S. Congressional Budget Office; Ray Hanley, Director, Division of Medical Services, Arkansas Department of Human Services; Parashar Patel, Deputy Director, Purchasing Policy Group, Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services
More information available in the accompanying publication, Issue Brief No. 775.
See also an update to that paper, "One Pill, Many Prices: Variation in Prescription Drug Prices in Selected Government Programs" (Issue Brief No. 807, August 29, 2005).